Form 4: Nuvalent CEO James Richard Porter Executes Stock Option and Sells Shares Under 10b5-1 Plan

Nuvalent's CEO, James Richard Porter, exercised stock options and sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• On February 18, 2025, James Richard Porter, the President and CEO of Nuvalent, Inc., executed a transaction involving the company's Class A Common Stock.
• Porter exercised stock options to acquire 27,000 shares at a price of $27.85 per share.
• Simultaneously, Porter sold 26,200 shares at a weighted average price of $78.44 and 800 shares at a weighted average price of $79.01.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on April 2, 2024.
• Following these transactions, Porter directly owns 249,062 shares of Class A Common Stock and holds options for 285,780 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of Nuvalent's CEO. It's common for executives to utilize 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

• Executive stock option exercises and sales are common across the pharmaceutical and biotechnology industries.
• Companies like Amgen, Gilead Sciences, and Vertex Pharmaceuticals also see regular Form 4 filings from their executives.
• The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
• The vesting schedule of the options (four years with monthly installments) is a typical arrangement for executive compensation packages in this sector.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The stock sales could exert downward pressure on the stock price, although the impact is likely to be minimal given the pre-planned nature of the sales.

Key Dates

Keywords

Nuvalent, James Richard Porter, Stock Options, Class A Common Stock, SEC Form 4, 10b5-1 Trading Plan, Executive Compensation, Insider Trading